Soundthinking, Inc. ((SSTI)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SoundThinking’s latest earnings call painted a company in transition, balancing solid strategic progress with uncomfortable short-term financial pressure. Management stressed momentum in new products, AI capabilities and hospital wins, while openly acknowledging revenue decline, margin compression and losses tied to SafePointe. Investors heard a steady reaffirmation of full-year guidance but with clear execution risks in the back half.
Q1 Results Steady Versus Expectations, Guidance Held
Q1 revenue came in at $24.2 million, essentially matching Street expectations despite a double‑digit year‑over‑year decline. Management reaffirmed full‑year 2026 revenue guidance of $109 million to $111 million and adjusted EBITDA margins of 16% to 18%, signaling confidence that a stronger second half will restore profitability metrics.
ARR Growth Ambitions Remain Intact
The company reiterated its goal of exiting 2026 with $110 million in annual recurring revenue, implying roughly 15% ARR growth for the year. That target underscores management’s focus on expanding subscription‑like revenue even as current period results reflect timing issues and contract churn.
Product Deployments Show Operational Momentum
Operationally, Q1 saw ShotSpotter coverage live across seven customer accounts, an added 50 PlateRanger cameras and 85 SafePointe lanes in service. SafePointe’s monthly recurring revenue more than doubled between January and March, suggesting early traction despite its role as a near‑term drag on earnings.
Hospital Contracts Validate SafePointe Strategy
Management highlighted a three‑year $3.2 million deal with a top‑five hospital chain, adding more than $1 million in ARR and signaling confidence from a marquee customer. The team also expects a roughly 15‑lane, three‑year contract near $1 million in value, reinforcing hospitals as a key vertical for the SafePointe portfolio.
AI Platform and SafetySmart Integration Advance
SoundThinking rolled out its SafetySmart Field Agent in beta to more than a dozen ShotSpotter agencies, integrating ShotSpotter, ResourceRouter and PlateRanger data into an AI‑driven interface. CrimeTracer’s third generation is already in market, as management positioned the company as an emerging integrated “physical AI” safety platform.
Drone Integrations Deepen Customer Embedment
ShotSpotter‑to‑drone integrations are now live in 16 cities, with recent deployments in Las Vegas, Pittsburgh, Tampa and Virginia Beach. Management cited real‑world cases, such as drones identifying an active shooter or locating a gunshot victim, as proof that these integrations enhance outcomes and strengthen customer stickiness.
International Expansion Begins to Take Shape
Deployments in Montevideo, Uruguay and Niterói, Brazil were showcased as early proof points for a broader Latin American strategy. The company has put in place in‑country sales leadership and is building a pipeline aimed at multiyear international expansion beyond its core U.S. base.
Cost Actions Target Future Operating Leverage
A workforce optimization effective April 1 is expected to generate roughly $4 million in annualized savings, with about $2.5 million flowing into 2026 adjusted EBITDA. Management believes additional operating leverage will emerge as revenue ramps in the second half, turning today’s cost moves into tomorrow’s margin expansion.
Revenue and Margins Under Pressure in Q1
Q1 revenue fell to $24.2 million from $28.3 million a year earlier, a 14.5% decline driven largely by the absence of about $3.5 million in prior‑year catch‑up revenue and a $0.5 million non‑renewed Puerto Rico contract. Gross profit slipped to $11.3 million, or 47% of revenue, down from $16.6 million and 59%, reflecting higher servicing costs and the tough comparison.
Profitability Metrics Weaken as Investments Mount
Adjusted EBITDA swung to a slight loss of about $0.1 million versus a $4.5 million profit in the prior year, highlighting the earnings hit from current investments. GAAP net loss widened sharply to around $7.0 million, or $0.54 per share, from about $1.5 million, underscoring the cost of funding SafePointe and platform growth.
SafePointe a Strategic Asset but Near-Term Drag
SafePointe currently carries more than $8 million in annualized adjusted EBITDA losses, improved from over $9 million in 2025 but still a meaningful drag. Management continues to frame it as a long‑term growth driver, expecting it to reach profitability around late 2027 or early 2028 even as it weighs on near‑term margins.
Liquidity and Deferred Revenue Edge Lower
Cash and cash equivalents ended Q1 at $14.2 million, down from $15.8 million at year‑end, while deferred revenue slid to $40.4 million from $43.9 million. The company maintains roughly $36 million of undrawn capacity on its credit line, with about $4 million currently borrowed, providing some flexibility as it navigates a back‑loaded year.
Execution Risk Around Large Deals and Attrition
Two large potential deals—a statewide CrimeTracer contract worth about $2.5 million in ARR and a possible Puerto Rico win worth roughly $2.7 million in ARR—are key to second‑half performance but still carry timing risk. Management also flagged elevated attrition due to tighter budgets and the end of ARPA funding, as well as seasonal revenue patterns that push more risk into later quarters.
Guidance Hinges on Back-Half Ramp and Cost Discipline
Forward guidance assumes a roughly $50 million first half and $60 million second half, with more than 90% of incremental revenue above the Q1 run‑rate expected to flow through to adjusted EBITDA. The company is banking on its $4 million in annualized cost savings, stronger ARR base and SafePointe growth to hit its 2026 revenue and margin targets despite SafePointe’s current drag.
SoundThinking’s call left investors weighing robust strategic momentum against visible short‑term financial strain. The company is leaning into AI, hospital security and international markets while tightening costs, but must still execute on large deals and manage attrition to deliver its back‑half‑heavy plan. For now, management’s reaffirmed guidance signals conviction, yet the path to profitability remains closely watched.

